1. Home
  2. EXPI vs AMPH Comparison

EXPI vs AMPH Comparison

Compare EXPI & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo eXp World Holdings Inc.

EXPI

eXp World Holdings Inc.

HOLD

Current Price

$6.76

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$17.41

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXPI
AMPH
Founded
2008
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
971.8M
IPO Year
2010
2005

Fundamental Metrics

Financial Performance
Metric
EXPI
AMPH
Price
$6.76
$17.41
Analyst Decision
Strong Buy
Buy
Analyst Count
2
8
Target Price
$9.75
$28.38
AVG Volume (30 Days)
823.3K
527.4K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
3.18%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
$500,147,681.00
$719,887,000.00
Revenue This Year
$6.26
$6.90
Revenue Next Year
$5.50
$4.64
P/E Ratio
N/A
$130.64
Revenue Growth
220.39
N/A
52 Week Low
$5.66
$17.03
52 Week High
$12.23
$31.26

Technical Indicators

Market Signals
Indicator
EXPI
AMPH
Relative Strength Index (RSI) 60.03 33.37
Support Level $5.68 $17.03
Resistance Level $6.87 $24.16
Average True Range (ATR) 0.23 0.84
MACD 0.04 -0.58
Stochastic Oscillator 81.56 2.89

Price Performance

Historical Comparison
EXPI
AMPH

About EXPI eXp World Holdings Inc.

eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: